Publication | Open Access

In Situ-Bound Antibodies Eluted From the Skin of Patients with Bullous Pemphogoid Are Preferentially Directed Against the 230-kD Bullous Pemphigoid Antigen

Autoimmune DiseaseImmunologySerologic TestingClinical DermatologySitu-bound Antibodies ElutedAutoimmunityAntibody ScreeningDermatologyDermatopathologyImmunotherapyMedicine